NCR2 and COVID-19: To investigate the involvement of NK cells in the pathogenesis of COVID-19, CD3−CD16+CD56dim and CD3−CD16−/+CD56bright NK cell subsets and their NKp30, NKp44, NKp46, NKG2A, NKG2D, CD57 and CD38 expression levels were detected by flow cytometry.